Literature DB >> 29720564

Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys.

Angela N Duke1, Zhiqiang Meng1, Donna M Platt1, John R Atack1, Gerard R Dawson1, David S Reynolds1, V V N Phani Babu Tiruveedhula1, Guanguan Li1, Michael Rajesh Stephen1, Werner Sieghart1, James M Cook1, James K Rowlett2.   

Abstract

In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzodiazepines), zolpidem (preferential binding to α1 subunit-containing GABAA receptors), HZ-166 (8-ethynyl-6-(2'-pyridine)-4H-2,5,10b-triaza-benzo[e]azulene-3-carboxylic acid ethyl ester; functionally selective with relatively high intrinsic efficacy for α2 and α3 subunit-containing GABAA receptors), MRK-696 [7-cyclobutyl-6-(2-methyl-2H-1,2,4-triazol-2-ylmethoxy)-3-(2-flurophenyl)-1,2,4-triazolo(4,3-b)pyridazine; no selectivity but partial intrinsic activity], and TPA023B 6,2'-diflouro-5'-[3-(1-hydroxy-1-methylethyl)imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile; partial intrinsic efficacy and selectivity for α2, α3, α5 subunit-containing GABAA receptors]. We further examined the role of α1 subunit-containing GABAA receptors in benzodiazepine-induced sedative effects by pretreating animals with the α1 subunit-preferring antagonist β-carboline-3-carboxylate-t-butyl ester (βCCT). Increasing doses of alprazolam and diazepam resulted in the emergence of observable ataxia, rest/sleep posture, and moderate and deep sedation. In contrast, zolpidem engendered dose-dependent observable ataxia and deep sedation but not rest/sleep posture or moderate sedation, and HZ-166 and TPA023 induced primarily rest/sleep posture. MRK-696 induced rest/sleep posture and observable ataxia. Zolpidem, but no other compounds, significantly increased tactile/oral exploration. The sedative effects engendered by alprazolam, diazepam, and zolpidem generally were attenuated by βCCT pretreatments, whereas rest/sleep posture and suppression of tactile/oral exploration were insensitive to βCCT administration. These data suggest that α2/3-containing GABAA receptor subtypes unexpectedly may mediate a mild form of sedation (rest/sleep posture), whereas α1-containing GABAA receptors may play a role in moderate/deep sedation.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29720564      PMCID: PMC5988000          DOI: 10.1124/jpet.118.249250

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

Authors:  Q Huang; X He; C Ma; R Liu; S Yu; C A Dayer; G R Wenger; R McKernan; J M Cook
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

2.  Practice guidelines for sedation and analgesia by non-anesthesiologists.

Authors: 
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

3.  Molecular and neuronal substrate for the selective attenuation of anxiety.

Authors:  K Löw; F Crestani; R Keist; D Benke; I Brünig; J A Benson; J M Fritschy; T Rülicke; H Bluethmann; H Möhler; U Rudolph
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

4.  Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.

Authors:  Bradford D Fischer; Stephanie C Licata; Rahul V Edwankar; Zhi-Jian Wang; Shengming Huang; Xiaohui He; Jianming Yu; Hao Zhou; Edward M Johnson; James M Cook; Roman Furtmüller; Joachim Ramerstorfer; Werner Sieghart; Bryan L Roth; Samarpan Majumder; James K Rowlett
Journal:  Neuropharmacology       Date:  2010-08-18       Impact factor: 5.250

5.  Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors.

Authors:  James K Rowlett; Snjezana Lelas; Walter Tornatzky; Stephanie C Licata
Journal:  Psychopharmacology (Berl)       Date:  2005-12-24       Impact factor: 4.530

6.  Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.

Authors:  J R Atack; D J Hallett; S Tye; K A Wafford; C Ryan; S M Sanabria-Bohórquez; Wai-Si Eng; R E Gibson; H D Burns; G R Dawson; R W Carling; L J Street; A Pike; I De Lepeleire; K Van Laere; G Bormans; J N de Hoon; A Van Hecken; R M McKernan; M G Murphy; R J Hargreaves
Journal:  J Psychopharmacol       Date:  2010-02-15       Impact factor: 4.153

7.  Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.

Authors:  Donna M Platt; James K Rowlett; Roger D Spealman; James Cook; Chunrong Ma
Journal:  Psychopharmacology (Berl)       Date:  2002-09-04       Impact factor: 4.530

8.  Models of neurological disease (substance abuse): self-administration in monkeys.

Authors:  Donna M Platt; Galen Carey; Roger D Spealman
Journal:  Curr Protoc Pharmacol       Date:  2011-12

9.  Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

Authors:  James K Rowlett; Donna M Platt; Snjezana Lelas; John R Atack; Gerard R Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

10.  Modulation of α5 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys.

Authors:  Daniela Rüedi-Bettschen; James K Rowlett; Sundari Rallapalli; Terry Clayton; James M Cook; Donna M Platt
Journal:  Alcohol Clin Exp Res       Date:  2012-11-05       Impact factor: 3.455

View more
  9 in total

1.  Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands.

Authors:  Kamal P Pandey; Zubair Ahmed Khan; Lalit K Golani; Prithu Mondal; Yeunus Mian; Farjana Rashid; V V N Phani Babu Tiruveedhula; Daniel E Knutson; Dishary Sharmin; Taukir Ahmed; Sepideh Rezvanian; Nicolas M Zahn; Leggy A Arnold; Jeffrey M Witkin; James M Cook
Journal:  ARKIVOC       Date:  2020-12-02       Impact factor: 1.140

2.  GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric Modulators.

Authors:  Lais F Berro; Daniela Rüedi-Bettschen; Jemma E Cook; Lalit K Golani; Guanguan Li; Rajwana Jahan; Farjana Rashid; James M Cook; James K Rowlett; Donna M Platt
Journal:  Alcohol Clin Exp Res       Date:  2019-04-08       Impact factor: 3.455

3.  Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABAA receptors.

Authors:  Zhiqiang Meng; Lais F Berro; Eileen K Sawyer; Daniela Rüedi-Bettschen; Jemma E Cook; Guanguan Li; Donna M Platt; James M Cook; James K Rowlett
Journal:  J Psychopharmacol       Date:  2019-10-31       Impact factor: 4.153

4.  Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.

Authors:  S L Huskinson; D M Platt; M Brasfield; M E Follett; T E Prisinzano; B E Blough; K B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2020-05-06       Impact factor: 4.530

5.  Alprazolam-induced EEG spectral power changes in rhesus monkeys: a translational model for the evaluation of the behavioral effects of benzodiazepines.

Authors:  Lais F Berro; John S Overton; Jaren A Reeves-Darby; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2021-02-16       Impact factor: 4.530

6.  Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABAA receptor subtypes.

Authors:  Angela N Duke; V V N Phani Babu Tiruveedhula; Dishary Sharmin; Daniel E Knutson; James M Cook; Donna M Platt; James K Rowlett
Journal:  Drug Alcohol Depend       Date:  2021-08-27       Impact factor: 4.492

7.  Receptor variants and the development of centrally acting medications
.

Authors:  Stuart A Neale; Kumiko Kambara; Thomas E Salt; Daniel Bertrand
Journal:  Dialogues Clin Neurosci       Date:  2019       Impact factor: 5.986

8.  8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor.

Authors:  Lalit K Golani; Donna M Platt; Daniela Rüedi-Bettschen; Chitra Edwanker; Shenming Huang; Michael M Poe; Roman Furtmüller; Werner Sieghart; James M Cook; James K Rowlett
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

9.  Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia.

Authors:  Miren Ettcheto; Jordi Olloquequi; Elena Sánchez-López; Oriol Busquets; Amanda Cano; Patricia Regina Manzine; Carlos Beas-Zarate; Rubén D Castro-Torres; Maria Luisa García; Mónica Bulló; Carme Auladell; Jaume Folch; Antonio Camins
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.